Porcine circovirus type 2 (PCV2): Pathogenesis and interaction with the immune system

Annual Review of Animal Biosciences

Volumn 1, Issue , 2013, Pages 43-64

  Meng, Xiang Jin ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

cytokines; immune interactions; PCV2; PCVAD,pathogenesis; PMWS; porcine circovirus type 2; porcine circovirus associated disease; postweaning multisystemic wasting syndrome

Indexed keywords

ANIMAL; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CLASSIFICATION; GENETICS; IMMUNOLOGY; PIG; SWINE DISEASE; VETERINARY; VIROLOGY; VIRUS GENOME;

ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; GENOME, VIRAL; SWINE; SWINE DISEASES;

EID: 84904409434     PISSN: 21658102     EISSN: 21658110     Source Type: Journal    
DOI: 10.1146/annurev-animal-031412-103720     Document Type: Article

References (137)

1. Ellis J, Hassard L, Clark E, Harding J, Allan G, et al. 1998. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can. Vet. J. 39:44-51
2. Meng XJ. 2012. Spread like a wildfire-the omnipresence of porcine circovirus type 2 (PCV2) and its ever-expanding association with diseases in pigs. Virus Res. 164:1-3
3. Allan G, Krakowka S, Ellis J, Charreyre C. 2012. Discovery and evolving history of two genetically related but phenotypically different viruses, porcine circoviruses 1 and 2. Virus Res. 164:4-9
4. Meng XJ. 2013. Circoviridae. In Fields Virology, ed. DM Knipe. Philadelphia, PA: Lippincott Williams & Wilkins. 6th ed. In press
5. Harding J. 1996. Postweaning multisystemic wasting syndrome (PMWS). Preliminary epidemiology and clinical presentation. Proc. West. Can. Assoc. Swine Pract. 1996:21
6. Clark EG. 1996. Post-weaning multisystemic wasting syndrome (PMWS). Preliminary epidemiology and clinical findings. Proc. West. Can. Assoc. Swine Pract. 1996:22-25
7. Opriessnig T, Meng X-J, Halbur PG. 2007. Porcine circovirus type 2-associated disease: Update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J. Vet. Diagn. Invest. 19:591-615
8. Segalés J. 2012. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res. 164:10-19
9. Mankertz A. 2012. Molecular interactions of porcine circoviruses type 1 and type 2 with its host. Virus Res. 164:54-60
10. Cheung AK. 2012. Porcine circovirus: transcription and DNA replication. Virus Res. 164:46-53
11. Ramamoorthy S, Meng XJ. 2009. Porcine circoviruses: a minuscule yet mammoth paradox. Anim. Health Res. Rev. 10:1-20
12. Opriessnig T, Halbur PG. 2012. Concurrent infections are important for expression of porcine circovirus associated disease. Virus Res. 164:20-32
13. Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, et al. 2010. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 84:6033-40
14. Beach NM,Meng XJ. 2012. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res. 164:33-42
15. Chae C. 2012. Porcine circovirus type 2 and its associated diseases in Korea. Virus Res. 164:107-13
16. Ge X, Wang F, Guo X, Yang H. 2012. Porcine circovirus type 2 and its associated diseases in China. Virus Res. 164:100-6
17. Rose N, Opriessnig T, Grasland B, Jestin A. 2012. Epidemiology and transmission of porcine circovirus type 2 (PCV2). Virus Res. 164:78-89
18. Darwich L, Mateu E. 2012. Immunology of porcine circovirus type 2 (PCV2). Virus Res. 164:61-67
19. Trible BR, Rowland RR. 2012. Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis. Virus Res. 164:68-77
20. Nauwynck HJ, Sanchez R, Meerts P, Lefebvre DJ, Saha D, et al. 2012. Cell tropism and entry of porcine circovirus 2. Virus Res. 164:43-45
21. Tischer I, Rasch R, Tochtermann G. 1974. Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl. Bakteriol. 226:153-67
22. Tischer I, Gelderblom H, Vettermann W,Koch MA.1982.Avery small porcine virus with circular singlestranded DNA. Nature 295:64-66
23. Tischer I, Mields W, Wolff D, Vagt M, Griem W. 1986. Studies on epidemiology and pathogenicity of porcine circovirus. Arch. Virol. 91:271-76
24. Allan GM,McNeilly F, Cassidy JP, Reilly GA, Adair B, et al. 1995. Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material. Vet. Microbiol. 44:49-64
25. Krakowka S, Ellis JA, Meehan B, Kennedy S, McNeilly F, Allan G. 2000. Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet. Pathol. 37:254-63
26. Fenaux M, Halbur PG, Haqshenas G, Royer R, Thomas P, et al. 2002. Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J. Virol. 76:541-51
27. Hamel AL, Lin LL, Nayar GP. 1998. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J. Virol. 72:5262-67
28. Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst VA, et al. 1998. Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J. Gen. Virol. 79:2171-79
29. Allan GM, Mackie DP, McNair J, Adair BM, McNulty MS. 1994. Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus. Vet. Immunol. Immunopathol. 43:357-71
30. Crowther RA, Berriman JA, Curran WL, Allan GM, Todd D. 2003. Comparison of the structures of three circoviruses: chicken anemia virus, porcine circovirus type 2, and beak and feather disease virus. J. Virol. 77:13036-41
31. Fenaux M, Opriessnig T, Halbur PG, Meng XJ. 2003. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J. Virol. 77:11232-43
32. Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng XJ. 2004. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J. Virol. 78:6297-303
33. Beach NM, Juhan NM, Cordoba L, Meng XJ. 2010. Replacement of the replication factors of porcine circovirus (PCV) type 2 with those of PCV type 1 greatly enhances viral replication in vitro. J. Virol. 84:8986-89
34. Beach NM, Ramamoorthy S, Opriessnig T,Wu SQ, Meng XJ. 2010. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the nonpathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs. Vaccine 29:221-32
35. Beach NM, Smith SM, Ramamoorthy S, Meng XJ. 2011. Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both antiepitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs. J. Virol. 85:4591-95
36. Gibbs MJ, Weiller GF. 1999. Evidence that a plant virus switched hosts to infect a vertebrate and then recombined with a vertebrate-infecting virus. Proc. Natl. Acad. Sci. USA 96:8022-27
37. Cheung AK. 2006. Rolling-circle replication of an animal circovirus genome in a theta-replicating bacterial plasmid in Escherichia coli. J. Virol. 80:8686-94
38. Walker IW, Konoby CA, Jewhurst VA, McNair I, McNeilly F, et al. 2000. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. J. Vet. Diagn. Invest. 12:400-5
39. Dupont K, Nielsen EO, Baekbo P, Larsen LE. 2008. Genomic analysis of PCV2 isolates from Danish archives and a currentPMWScase-control study supports a shift in genotypes with time. Vet. Microbiol. 128:56-64
40. Cheung AK, Lager KM, Kohutyuk OI, Vincent AL, Henry SC, et al. 2007. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Arch. Virol. 152:1035-44
41. Olvera A, Cortey M, Segalés J. 2007. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 357:175-85
42. Opriessnig T, Ramamoorthy S, Madson DM, Patterson AR, Pal N, et al. 2008. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. J. Gen. Virol. 89:2482-91
43. McKeown NE, Opriessnig T, Thomas P, Guenette DK, Elvinger F, et al. 2005. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clin. Diagn. Lab. Immunol. 12:1347-51
44. Allan GM, Ellis JA. 2000. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 12:3-14
45. Harms PA, Sorden SD, Halbur PG, Bolin SR, LagerKM,et al. 2001. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet. Pathol. 38:528-39
46. Kim J, Chung HK, Chae C. 2003. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet. J. 166:251-56
47. Kim J, Ha Y, Jung K, Choi C, Chae C. 2004. Enteritis associated with porcine circovirus 2 in pigs. Can. J. Vet. Res. 68:218-21
48. Opriessnig T, Madson DM, Roof M, Layton SM, Ramamoorthy S, et al. 2011. Experimental reproduction of porcine circovirus type 2 (PCV2)-associated enteritis in pigs infected with PCV2 alone or concurrently with Lawsonia intracellularis or Salmonella typhimurium. J. Comp. Pathol. 145:261-70
49. Jensen TK, Vigre H, Svensmark B, Bille-Hansen V. 2006. Distinction between porcine circovirus type 2 enteritis and porcine proliferative enteropathy caused by Lawsonia intracellularis. J. Comp. Pathol. 135:176-82
50. Bolin SR, Stoffregen WC, Nayar GP, Hamel AL. 2001. Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J. Vet. Diagn. Invest. 13:185-94
51. Ladekjaer-Mikkelsen AS, Nielsen J, Storgaard T, Bøtner A, Allan G, McNeilly F. 2001. Transplacental infection with PCV-2 associated with reproductive failure in a gilt. Vet. Rec. 148:759-60
52. O'Connor B, Gauvreau H, West K, Bogdan J, Ayroud M, et al. 2001. Multiple porcine circovirus 2-associated abortions and reproductive failure in a multisite swine production unit. Can. Vet. J. 42:551-53
53. Park JS, Kim J, Ha Y, Jung K, Choi C, et al. 2005. Birth abnormalities in pregnant sows infected intranasally with porcine circovirus 2. J. Comp. Pathol. 132:139-44
54. RosellC, Segalés J,Ramos-Vara JA, Folch JM,Rodríguez- ArriojaGM,et al. 2000. Identification of porcine circovirus in tissues of pigs with porcine dermatitis and nephropathy syndrome. Vet. Rec. 146:40-43
55. Wellenberg GJ, Stockhofe-Zurwieden N, de Jong MF, Boersma WJ, Elbers AR. 2004. Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study. Vet. Microbiol. 99:203-14
56. Pallarés FJ, Halbur PG, Opriessnig T, Sorden SD, Villar D, et al. 2002. Porcine circovirus type 2 (PCV-2) coinfections in US field cases of postweaning multisystemic wasting syndrome (PMWS). J. Vet. Diagn. Invest. 14:515-19
57. Dorr PM, Baker RB, AlmondGW,Wayne SR, GebreyesWA.2007. Epidemiologic assessment of porcine circovirus type 2 coinfection with other pathogens in swine. J. Am. Vet. Med. Assoc. 230:244-50
58. Pogranichniy RM, Yoon KJ, Harms PA, Sorden SD, Daniels M. 2002. Case-control study on the association of porcine circovirus type 2 and other swine viral pathogens with postweaning multisystemic wasting syndrome. J. Vet. Diagn. Invest. 14:449-56
59. Opriessnig T, McKeown NE, Harmon KL, Meng XJ, Halbur PG. 2006. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine. Clin. Vaccine Immunol. 13:923-29
60. Ellis JA, Bratanich A, Clark EG, Allan G, Meehan B, et al. 2000. Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome. J. Vet. Diagn. Invest. 12:21-27
61. Ellis J, Krakowka S, Lairmore M, Haines D, Bratanich A, et al. 1999. Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J. Vet. Diagn. Invest. 11:3-14
62. Opriessnig T, Fenaux M, Yu S, Evans RB, Cavanaugh D, et al. 2004. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus. Vet. Microbiol. 98:209-20
63. Opriessnig T, Thacker EL, Yu S, Fenaux M, Meng X-J, Halbur PG. 2004. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet. Pathol. 41:624-40
64. Madson DM, Opriessnig T. 2011. Effect of porcine circovirus type 2 (PCV2) infection on reproduction: disease, vertical transmission, diagnostics and vaccination. Anim. Health Res. Rev. 12:47-65
65. Darwich L, Segalés J, Domingo M, Mateu E. 2002. Changes in CD4\+, CD8\+, CD4\+ CD8\+, and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus type 2 load in lymphoid tissues. Clin. Diagn. Lab. Immunol. 9:236-42
66. Grierson SS, King DP, Tucker AW, Donadeu M, Mellencamp MA, et al. 2007. Ontogeny of systemic cellular immunity in the neonatal pig: correlation with the development of post-weaning multisystemic wasting syndrome. Vet. Immunol. Immunopathol. 119:254-68
67. Liu J, Chen I, Kwang J. 2005. Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J. Virol. 79:8262-74
68. Mankertz A, Caliskan R, Hattermann K, Hillenbrand B, Kurzendoerfer P, et al. 2004.Molecular biology of porcine circovirus: analyses of gene expression and viral replication. Vet. Microbiol. 98:81-88
69. Liu J, Chen I, Du Q, Chua H, Kwang J. 2006. The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J. Virol. 80:5065-73
70. Karuppannan AK, Liu S, Jia Q, Selvaraj M, Kwang J. 2010. Porcine circovirus type 2 ORF3 protein competes with p53 in binding to Pirh2 and mediates the deregulation of p53 homeostasis. Virology 398:1-11
71. Juhan NM, LeRoith T, Opriessnig T, Meng XJ. 2010. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant. Virus Res. 147:60-66
72. Shibahara T, Sato K, Ishikawa Y, Kadota K. 2000. Porcine circovirus induces B lymphocyte depletion in pigs with wasting disease syndrome. J. Vet. Med. Sci. 62:1125-31
73. Kiupel M, Stevenson GW, Choi J, Latimer KS, Kanitz CL, Mittal SK. 2001. Viral replication and lesions in BALB/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease. Vet. Pathol. 38:74-82
74. Mandrioli L, Sarli G, Panarese S, Baldoni S, Marcato PS. 2004. Apoptosis and proliferative activity in lymph node reaction in postweaning multisystemic wasting syndrome (PMWS). Vet. Immunol. Immunopathol. 97:25-37
75. Krakowka S, Ellis J, McNeilly F, Meehan B, Oglesbee M, et al. 2004. Features of cell degeneration and death in hepatic failure and systemic lymphoid depletion characteristic of porcine circovirus-2-associated postweaning multisystemic wasting disease. Vet. Pathol. 41:471-81
76. Resendes AR, Majó N, Segalés J, Mateu E, Calsamiglia M, Domingo M. 2004. Apoptosis in lymphoid organs of pigs naturally infected by porcine circovirus type 2. J. Gen. Virol. 85:2837-44
77. Lager KM, Gauger PC, Vincent AL,Opriessnig T, Kehrli ME Jr, Cheung AK. 2007.Mortality in pigs given porcine circovirus type 2 subgroup 1 and 2 viruses derived from DNA clones. Vet. Rec. 161:428-29
78. Harding JC, Ellis JA, McIntosh KA, Krakowka S. 2010. Dual heterologous porcine circovirus genogroup 2a/2b infection induces severe disease in germ-free pigs. Vet. Microbiol. 145:209-19
79. Larochelle R, Magar R, D'Allaire S. 2002. Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Virus Res. 90:101-12
80. Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng XJ. 2004. Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhancedPCV2 replication in vitro and attenuated the virus in vivo. J. Virol. 78:13440-46
81. Krakowka S, Allan G, Ellis J, Hamberg A, Charreyre C, et al. 2012. A nine-base nucleotide sequence in the porcine circovirus type 2 (PCV2) nucleocapsid gene determines viral replication and virulence. Virus Res. 164:90-99
82. Opriessnig T, Fenaux M, Thomas P, Hoogland MJ, Rothschild MF, et al. 2006. Evidence of breeddependent differences in susceptibility to porcine circovirus type-2-associated disease and lesions. Vet. Pathol. 43:281-93
83. Opriessnig T, Patterson AR, Madson DM, Pal N, Rothschild M, et al. 2009. Difference in severity of porcine circovirus type two-induced pathological lesions between Landrace and Pietrain pigs. J. Anim. Sci. 87:1582-90
84. López-Soria S, Nofrarías M, Calsamiglia M, Espinal A, Valero O, et al. 2011. Post-weaning multisystemic wasting syndrome (PMWS) clinical expression under field conditions is modulated by the pig genetic background. Vet. Microbiol. 149:352-57
85. Krakowka S, Ellis JA, McNeilly F, Ringler S, Rings DM, Allan G. 2001. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet. Pathol. 38:31-42
86. Krakowka S, Ellis J, McNeilly F, Waldner C, Rings DM, Allan G. 2007. Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease. Can. Vet. J. 48:716-24
87. Allan GM, McNeilly F, Kennedy S, Meehan B, Ellis J, Krakowka S. 2000. Immunostimulation, PCV-2 and PMWS. Vet. Rec. 147:170-71
88. Ladekjaer-Mikkelsen AS, Nielsen J, Stadejek T, Storgaard T, Krakowka S, et al. 2002. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and nonimmunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet. Microbiol. 89:97-114
89. Yu S, Vincent A, Opriessnig T, Carpenter S, Kitikoon P, et al. 2007. Quantification of PCV2 capsid transcript in peripheral blood mononuclear cells (PBMCs) in vitro. Vet. Microbiol. 123:34-42
90. Yu S, Halbur PG, Thacker E. 2009. Effect of porcine circovirus type 2 infection and replication on activated porcine peripheral blood mononuclear cells in vitro. Vet. Immunol. Immunopathol. 127:350-56
91. Chang HW, Jeng CR, Lin TL, Liu JJ, Chiou MT, et al. 2006. Immunopathological effects of porcine circovirus type 2 (PCV2) on swine alveolar macrophages by in vitro inoculation. Vet. Immunol. Immunopathol. 110:207-19
92. Chang HW, Pang VF, Chen LJ, Chia MY, Tsai YC, Jeng CR. 2006. Bacterial lipopolysaccharide induces porcine circovirus type 2 replication in swine alveolar macrophages. Vet. Microbiol. 115:311-19
93. Gilpin DF, McCullough K, Meehan BM, McNeilly F, McNair I, et al. 2003. In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Vet. Immunol. Immunopathol. 94:149-61
94. Vincent IE, Carrasco CP, Guzylack-Piriou L, Herrmann B, McNeilly F, et al. 2005. Subset-dependent modulation of dendritic cell activity by circovirus type 2. Immunology 115:388-98
95. Vincent IE, Carrasco CP, Herrmann B, Meehan BM, Allan GM, et al. 2003. Dendritic cells harbor infectious porcine circovirus type 2 in the absence of apparent cell modulation or replication of the virus. J. Virol. 77:13288-300
96. Kekarainen T, Montoya M, Dominguez J, Mateu E, Segalés J. 2008. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Vet. Immunol. Immunopathol. 124:41-49
97. Steiner E, Balmelli C, Herrmann B, Summerfield A, McCullough K. 2008. Porcine circovirus type 2 displays pluripotency in cell targeting. Virology 378:311-22
98. Vincent IE, Balmelli C, Meehan B, Allan G, Summerfield A, McCullough KC. 2007. Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA. Immunology 120:47-56
99. Darwich L, Balasch M, Plana-Durán J, Segalés J, Domingo M, Mateu E. 2003. Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens. J. Gen. Virol. 84:3453-57
100. Darwich L, Pié S, Rovira A, Segalés J, Domingo M, et al. 2003. Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome. J. Gen. Virol. 84:2117-25
101. Darwich L, Segalés J, Resendes A, Balasch M, Plana-Durán J, Mateu E. 2008. Transient correlation between viremia levels and IL-10 expression in pigs subclinically infected with porcine circovirus type 2 (PCV2). Res. Vet. Sci. 84:194-98
102. Kim J, Chae C. 2004. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation. J. Comp. Pathol. 131:121-26
103. Stevenson LS, McCullough K, Vincent I, Gilpin DF, Summerfield A, et al. 2006. Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3-week-old piglets. Viral Immunol. 19:189-95
104. Misinzo G, Delputte PL, Meerts P, Lefebvre DJ, Nauwynck HJ. 2006. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J. Virol. 80:3487-94
105. Misinzo G, Meerts P, Bublot M, Mast J, Weingartl HM, Nauwynck HJ. 2005. Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4/31. J. Gen. Virol. 86: 2057-68
106. Misinzo G, Delputte PL, Lefebvre DJ, Nauwynck HJ. 2009. Porcine circovirus 2 infection of epithelial cells is clathrin-, caveolae-and dynamin-independent, actin and Rho-GTPase-mediated, and enhanced by cholesterol depletion. Virus Res. 139:1-9
107. Bratanich A, Blanchetot A. 2006. A gene similar to the human hyaluronan-mediated motility receptor (RHAMM) gene is upregulated during Porcine Circovirus type 2 infection. Virus Genes 32:145-52
108. Lee G, Han D, Song JY, Lee YS, Kang KS, Yoon S. 2010. Genomic expression profiling in lymph nodes with lymphoid depletion from porcine circovirus 2-infected pigs. J. Gen. Virol. 91:2585-91
109. Finsterbusch T, Steinfeldt T, Doberstein K, Rödner C, Mankertz A. 2009. Interaction of the replication proteins and the capsid protein of porcine circovirus type 1 and 2 with host proteins. Virology 386:122-31
110. Timmusk S, Fossum C, Berg M. 2006. Porcine circovirus type 2 replicase binds the capsid protein and an intermediate filament-like protein. J. Gen. Virol. 87:3215-23
111. Timmusk S, Merlot E, Lövgren T, Järvekülg L, Berg M, Fossum C. 2009. Regulator of G protein signalling 16 is a target for a porcine circovirus type 2 protein. J. Gen. Virol. 90:2425-36
112. Wei L, Kwang J, Wang J, Shi L, Yang B, et al. 2008. Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IkBa degradation. Virology 378:177-84
113. Hasslung FC, Berg M, Allan GM,Meehan BM, McNeilly F, Fossum C. 2003. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-a production by porcine PBMCs. J. Gen. Virol. 84:2937-45
114. Wikström FH, Meehan BM, Berg M, Timmusk S, Elving J, et al. 2007. Structure-dependent modulation of alpha interferon production by porcine circovirus 2 oligodeoxyribonucleotide and CpG DNAs in porcine peripheral blood mononuclear cells. J. Virol. 81:4919-27
115. Meerts P, Misinzo G, Nauwynck HJ. 2005. Enhancement of porcine circovirus 2 replication in porcine cell lines by IFN-g before and after treatment and by IFN-a after treatment. J. Interferon Cytokine Res. 25:684-93
116. Mankertz A, Hillenbrand B. 2002. Analysis of transcription of Porcine circovirus type 1. J. Gen. Virol. 83:2743-51
117. Ramamoorthy S, Huang FF, Huang YW,Meng XJ. 2009. Interferon-mediated enhancement of in vitro replication of porcine circovirus type 2 is influenced by an interferon-stimulated response element in the PCV2 genome. Virus Res. 145:236-43
118. Ramamoorthy S, Opriessnig T, Pal N, Huang FF, Meng XJ. 2011. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model. Vet. Microbiol. 147:49-58
119. Opriessnig T, Madson DM, Schalk S, Brockmeier S, Shen HG, et al. 2011. Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae. Theriogenology 76:351-60
120. Opriessnig T, Patterson AR, Madson DM, Pal N, Ramamoorthy S, et al. 2010. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derivedPCV2vaccine-induced immunity on vaccination. Vet. Microbiol. 142:177-83
121. Opriessnig T, Patterson AR, Madson DM, Pal N, Halbur PG. 2009. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 27:1002-7
122. Segalés J, Urniza A, Alegre A, Bru T, Crisci E, et al. 2009. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 27:7313-21
123. Sinha A, Shen HG, Schalk S, Beach NM, Huang YW, et al. 2010. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy. Clin. Vaccine Immunol. 17:1940-45
124. Shen HG, Beach NM, Huang YW, Halbur PG, Meng XJ, Opriessnig T. 2010. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 28:5960-66
125. Kim D, Kim CH, Han K, Seo HW, Oh Y, et al. 2011. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Vaccine 29:3206-12
126. Lekcharoensuk P, Morozov I, Paul PS, Thangthumniyom N, Wajjawalku W, Meng XJ. 2004. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J. Virol. 78:8135-45
127. Meerts P, Van Gucht S, Cox E, Vandebosch A, Nauwynck HJ. 2005. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol. 18:333-41
128. Meerts P, Misinzo G, Lefebvre D, Nielsen J, Bøtner A, et al. 2006. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet. Res. 2:6
129. Song Y, Jin M, Zhang S, Xu X, Xiao S, et al. 2007. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2. Vet. Microbiol. 119:97-104
130. Mahé D, Blanchard P, Truong C, Arnauld C, Le Cann P, et al. 2000. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J. Gen. Virol. 81:1815-24
131. Truong C, MaheD, Blanchard P, Le DimnaM,Madec F, et al. 2001. Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch. Virol. 146:1197-211
132. Fort M, Sibila M, Pérez-Martín E, Nofrarías M, Mateu E, Segalés J. 2009. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cellmediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 27:4031-37
133. Steiner E, Balmelli C, Gerber H, Summerfield A, McCullough K. 2009. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. BMC Vet. Res. 5:45.
134. Grierson SS, King DP, Sandvik T, Hicks D, Spencer Y, et al. 2004. Detection and genetic typing of type 2 porcine circoviruses in archived pig tissues from the UK. Arch. Virol. 149:1171-83
135. Beach NM, Córdoba L, Kenney SP, Meng XJ. 2011. Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1. Vaccine 29:7303-6
136. Delwart E, Li L. 2012. Rapidly expanding genetic diversity and host range of the Circoviridae viral family and other Rep encoding small circular ssDNA genomes. Virus Res. 164:114-21
137. Finsterbusch T, Mankertz A. 2009. Porcine circoviruses-small but powerful. Virus Res. 143:177-83